Pdgfra and Pdgfrb genetically interact during craniofacial development

Neil McCarthy1, Jocelyn S Liu2, Alicia M Richarte3

  • 1Department of Molecular Biosciences, Institute for Cellular and Molecular Biology, Institute for Neuroscience, Waggoner Center for Alcohol and Addiction Research, University of Texas, Austin, Texas.

Insights

Platelet-derived growth factor receptors (Pdgfra and Pdgfrb) interact during palate development. This interaction is crucial for proper neural crest cell condensation, impacting palatogenesis in both zebrafish and mouse models.

Area of Science:

  • Developmental Biology
  • Craniofacial Development
  • Molecular Biology

Background:

  • Cleft palate is a common congenital birth defect.
  • Platelet-derived growth factors (Pdgf) are essential for palatogenesis.
  • Pdgfra is known to be required for neural crest migration and palate formation.

Purpose of the Study:

  • To investigate the role of pdgfrb in neural crest development.
  • To determine if pdgfra and pdgfrb interact during palatogenesis.

Main Methods:

  • Zebrafish and mouse models were used.
  • Analysis of pdgfra and pdgfrb single and double mutants.
  • Time-lapse confocal microscopy and pharmacological analyses were employed.

Main Results:

  • Pdgfrb is dispensable for craniofacial development in zebrafish.
  • Palatal defects in pdgfra;pdgfrb double mutants were more severe than in pdgfra single mutants.
  • A failure in neural crest condensation was observed in double mutants, indicating an interaction between Pdgfra and Pdgfrb.

Conclusions:

  • Pdgfra and Pdgfrb interact during palatogenesis in both zebrafish and mouse.
  • This interaction is critical for the proper condensation of maxillary neural crest cells.
  • A novel interaction between Pdgfra and Pdgfrb in palate formation has been identified.
Abstract

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.9K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.7K
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
7.1K
Determination01:51

Determination

During embryogenesis, cells become progressively committed to different fates through a two-step process: specification followed by determination. Specification is demonstrated by removing a segment of an early embryo, “neutrally” culturing the tissue in vitro—for example, in a petri dish with simple medium—and then observing the derivatives. If the cultured region gives rise to cell types that it would normally generate in the embryo, this means that it is specified. In...
21.4K
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
7.4K